Idarucizumab rapidly reverses the anticoagulant effect of dabigatran | ISTH

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • Idarucizumab rapidly, durably, and safely reverses the anticoagulant effect of dabigatran. 

Why this matters

  • In emergency settings, rapid reversal of the anticoagulant effect of dabigatran is critical to patient management; this study, RE-VERSE AD is the first clinical trial ...